ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0152

Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations

Debbie Ehrmann Feldman1 and Barbara Mazer2, 1Université de Montréal, Montreal, QC, Canada, 2McGill University, Montreal, QC, Canada

Meeting: ACR Convergence 2023

Keywords: COVID-19, Epidemiology, functional status

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0145–0154) Epidemiology & Public Health – Interprofessional Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Long covid, a condition whereby signs and symptoms post covid-19 infection continue for more than 12 weeks and are not explained by an alternative diagnosis, may be more frequent among persons with arthritis. Currently, little is known whether persons with arthritis are at higher risk for long covid and how long covid affects their function. Our objectives are 1) to describe long covid in a cohort of persons with a self-reported history of arthritis who had been diagnosed with covid-19 in terms of frequency, symptoms and associated factors; and 2) to describe change in function in persons with arthritis and long covid compared to pre-covid status, focusing on: perceived global health status, mobility, personal care, participation in daily activities, and employment.

Methods: Among 2764 persons with a confirmed covid-19 diagnosis who responded to an online survey, 171 reported a history of arthritis and formed our study sample. The survey included validated questionnaires: the Newcastle Post-Covid Syndrome Questionnaire and the Covid-19 Yorkshire Rehabilitation Screen. We calculated the frequency of long covid (defined as those still troubled by symptoms) and persistent symptoms, and evaluated associated factors using bivariate analysis and multivariable logistic regression. Among those with long covid, we describe limitations in activity and function in comparison to pre-covid status. Change was calculated by subtracting the current functional score from the pre-covid 19 score and we categorized degree of change as small, moderate and severe.

Results: In our sample, 53.5% were still troubled by symptoms and the most frequent symptoms were: fatigue, myalgia, weakness, breathlessness, low mood, anxiety, and sleep disturbance. Factors associated with long covid were female sex, having been hospitalized for covid, and having at least one other chronic disease. Persons with long covid had substantial declines in function, notably in global health status, usual activities, mobility, personal care, and employment status. For example, 9.3% had major problems with usual activities pre-covid and this proportion rose to 52.5% with long covid. Fatigue was a big problem with 88% reporting a change and 52% reporting the decline as being moderate to severe. Also, 37% reported moderate to severe increase in pain.

Conclusion: Persons with arthritis and long covid have substantial limitations in function compared to pre-covid status. There is a need to implement effective interventions to improve functional status in persons with arthritis and long covid.


Disclosures: D. Ehrmann Feldman: None; B. Mazer: None.

To cite this abstract in AMA style:

Ehrmann Feldman D, Mazer B. Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/long-covid-in-persons-with-self-reported-arthritis-symptoms-associated-factors-and-functional-limitations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/long-covid-in-persons-with-self-reported-arthritis-symptoms-associated-factors-and-functional-limitations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology